{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:17:24Z","timestamp":1757704644803},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.ccl.2007.08.011","type":"journal-article","created":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T04:28:59Z","timestamp":1208924939000},"page":"91-105","source":"Crossref","is-referenced-by-count":6,"title":["Aldosterone Receptor Blockade in Patients with Left Ventricular Systolic Dysfunction Following Acute Myocardial Infarction"],"prefix":"10.1016","volume":"26","author":[{"given":"Filippo","family":"Brandimarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.A.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Manuchehry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccl.2007.08.011_bib1","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","article-title":"Heart disease and stroke statistics\u20142007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"115","author":"Rosamond","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1067\/mhj.2003.53","article-title":"Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials","volume":"145","author":"Hasdai","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2007.08.011_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.CIR.0000109691.16944.DA","article-title":"Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE)","volume":"109","author":"Steg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0735-1097(02)02173-3","article-title":"Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2)","volume":"40","author":"Wu","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib5","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ehj.2004.08.006","article-title":"An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry","volume":"25","author":"Velazquez","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2007.08.011_bib6","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/01.CIR.0000017861.00991.2F","article-title":"Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction","volume":"105","author":"Spencer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib7","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0735-1097(99)00390-3","article-title":"Twenty year trends (1975\u20131995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective","volume":"34","author":"Spencer","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib8","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib9","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1056\/NEJMoa043938","article-title":"Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib10","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib13","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.jacc.2006.07.010","volume":"48","author":"Zipes","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 3","key":"10.1016\/j.ccl.2007.08.011_bib14","first-page":"S3","article-title":"New concepts in post-infarction ventricular remodeling","volume":"4","author":"Udelson","year":"2003","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib15","series-title":"Harrison's principles of internal medicine","author":"Harrison","year":"2005"},{"key":"10.1016\/j.ccl.2007.08.011_bib16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.CIR.81.4.1161","article-title":"Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications","volume":"81","author":"Pfeffer","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib17","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib18","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction","volume":"114","author":"Beygui","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib19","doi-asserted-by":"crossref","first-page":"H647","DOI":"10.1152\/ajpheart.2001.281.2.H647","article-title":"Effect of a selective aldosterone receptor antagonist in myocardial infarction","volume":"281","author":"Delyani","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib20","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1161\/01.CIR.0000039104.56479.42","article-title":"Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure","volume":"106","author":"Suzuki","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib21","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2003.05.003","article-title":"Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction","volume":"42","author":"Fraccarollo","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1071-9164(03)00578-5","article-title":"Role of a selective aldosterone blocker in mice with chronic heart failure","volume":"10","author":"Wang","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.ccl.2007.08.011_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cardfail.2004.02.010","article-title":"Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarction","volume":"10","author":"Masson","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.ccl.2007.08.011_bib24","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","article-title":"Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis","volume":"99","author":"Silvestre","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.CIR.0000138973.55605.38","article-title":"Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction","volume":"110","author":"Perrier","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0922-4106(95)90018-7","article-title":"Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 beta","volume":"290","author":"Ikeda","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ccl.2007.08.011_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/jmcc.1998.0839","article-title":"NO: the primary EDRF","volume":"31","author":"Fleming","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib28","first-page":"H670","article-title":"Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure","volume":"266","author":"Wang","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib29","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/01.CIR.100.12.1338","article-title":"Improvement of endocardial and vascular endothelial function on myocardial performance by captopril treatment in postinfarct rat hearts","volume":"100","author":"Qi","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0735-1097(01)01729-6","article-title":"Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression","volume":"39","author":"Bauersachs","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib31","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ccl.2007.08.011_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11906-000-0017-z","article-title":"Aldosterone and vascular damage","volume":"2","author":"Duprez","year":"2000","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ccl.2007.08.011_bib33","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","article-title":"Left ventricular remodeling after myocardial infarction: pathophysiology and therapy","volume":"101","author":"Sutton","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jmcc.1994.1098","article-title":"Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone","volume":"26","author":"Brilla","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib35","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/01.CIR.47.6.1174","article-title":"Left ventricular size after acute myocardial infarction. Serial changes and their prognostic significance","volume":"47","author":"Kostuk","year":"1973","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM197901113000202","article-title":"Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography","volume":"300","author":"Eaton","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJM198308113090602","article-title":"Risk stratification and survival after myocardial infarction","volume":"309","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","article-title":"Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients","volume":"35","author":"MacFadyen","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ccl.2007.08.011_bib39","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.HYP.24.5.571","article-title":"Chronic administration of aldosterone depresses baroreceptor reflex function in the dog","volume":"24","author":"Wang","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.ccl.2007.08.011_bib41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/CS19980176","article-title":"Aldosterone blunts the baroreflex response in man","volume":"95","author":"Yee","year":"1998","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ccl.2007.08.011_bib42","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","article-title":"Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease","volume":"76","author":"Barr","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib43","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0735-1097(01)01243-8","article-title":"Circadian variation in the effects of aldosterone blockade on\u00a0heart rate variability and QT dispersion in congestive heart failure","volume":"37","author":"Yee","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1113\/jphysiol.2005.092692","article-title":"A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice","volume":"569","author":"Perrier","year":"2005","journal-title":"J Physiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib45","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0008-6363(03)00333-X","article-title":"Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction","volume":"58","author":"Schafer","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ccl.2007.08.011_bib46","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1006\/jmcc.2002.2115","article-title":"Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat","volume":"34","author":"De Angelis","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib47","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/01.CIR.0000081442.99984.EF","article-title":"Potential antiapoptotic activity of aldosterone antagonists in postinfarction remodeling","volume":"108","author":"Biondi-Zoccai","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mhj.2001.111258","article-title":"Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction","volume":"141","author":"Modena","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2007.08.011_bib49","first-page":"121","article-title":"Additional beneficial effects of canrenoate in patients with anterior myocardial infarction on ACE-inhibitor treatment. A pilot study","volume":"2","author":"Di Pasquale","year":"2001","journal-title":"Ital Heart J"},{"key":"10.1016\/j.ccl.2007.08.011_bib50","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib51","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib52","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-126-4-199702150-00006","article-title":"Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction","volume":"126","author":"Aronson","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib53","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejheart.2005.11.008","article-title":"Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction <or=30%","volume":"8","author":"Pitt","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ccl.2007.08.011_bib55","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib56","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib57","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/eurheartj\/ehm091","article-title":"A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure","volume":"28","author":"Ahmed","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2007.08.011_bib58","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib59","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ccl.2007.08.011_bib60","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0002-8703(89)90866-1","article-title":"Life-threatening hyperkalemia in severe heart failure","volume":"117","author":"Chakko","year":"1989","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2007.08.011_bib61","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1161\/CIRCULATIONAHA.107.181940","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.08.011_bib62","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"beta Blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ccl.2007.08.011_bib63","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","article-title":"Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction","volume":"339","author":"Gottlieb","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib64","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","author":"Kober","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib65","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib66","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2007.08.011_bib67","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2007.08.011_bib68","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2007.08.011_bib69","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"CARE: the effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.08.011_bib70","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0002-9149(00)01230-3","article-title":"L-CAD: beneficial effects of pravastatin (+\/-colestyramine\/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study)","volume":"86","author":"Arntz","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2007.08.011_bib71","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"MIRACL: effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2007.08.011_bib72","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/jama.285.4.430","article-title":"RIKS-HIA: early statin treatment following acute myocardial infarction and 1-year survival","volume":"285","author":"Stenestrand","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2007.08.011_bib73","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"PROVE IT-TIMI 22: intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865107000835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865107000835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T13:00:23Z","timestamp":1557493223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865107000835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0733865107000835"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2007.08.011","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}